PRESS RELEASE published on 05/13/2025 at 07:45, 1 year 2 months ago Eckert & Ziegler Starts with Earnings Growth in Q1 2025 and Confirms Full-Year Forecast Eckert & Ziegler SE reports earnings growth in Q1 2025 with sales of €68.2 million and net income of €9.7 million. Full-year forecast for 2025 confirmed at around €320 million in sales and €78 million in EBIT EBIT Forecast Earnings Growth Sales Forecast Eckert & Ziegler SE Q1 2025
BRIEF published on 04/24/2025 at 14:05, 1 year 3 months ago Eckert & Ziegler Signs Manufacturing Agreement with Pentixapharm Clinical Trials Cancer Therapy Manufacturing Agreement Radiopharmaceuticals Y90-PentixaTher
PRESS RELEASE published on 04/24/2025 at 14:00, 1 year 3 months ago Eckert & Ziegler Signs Contract Manufacturing Agreement for Yttrium-90-based PentixaTher with Pentixapharm Eckert & Ziegler SE signs manufacturing agreement with Pentixapharm for Y90-PentixaTher, a targeted radiolabeled peptide therapeutic for cancer treatment Manufacturing Agreement Eckert & Ziegler SE Radiopharmaceuticals Pentixapharm Y90-PentixaTher
BRIEF published on 04/11/2025 at 10:35, 1 year 3 months ago Eckert & Ziegler Proposes €0.50 Dividend for FY 2024 Annual General Meeting Dividend Eckert & Ziegler Financial Year 2024 TecDax
PRESS RELEASE published on 04/11/2025 at 10:30, 1 year 3 months ago Eckert & Ziegler Proposes Dividend of € 0.50 for FY 2024 Eckert & Ziegler SE proposes dividend of €0.50 per share for FY 2024. The Annual General Meeting to be held on June 18, 2025 in Berlin Annual General Meeting Shareholders Dividend Eckert & Ziegler SE FY 2024
BRIEF published on 04/10/2025 at 15:05, 1 year 3 months ago Eckert & Ziegler: US Consul Visits Braunschweig Radiopharmaceutical Facility Cancer Treatment Radiopharmaceuticals Lutetium-177 US Consul Visit Expansion Investment
PRESS RELEASE published on 04/10/2025 at 15:00, 1 year 3 months ago Eckert & Ziegler: US Consul Visits Radiopharmaceutical Production in Braunschweig US Consul General Jason Chue visits Eckert & Ziegler's radiopharmaceutical production site in Braunschweig, witnessing the production of cancer diagnostics and therapy solutions Eckert & Ziegler Cancer Therapy Radiopharmaceuticals Lutetium-177 Transatlantic Cooperation
BRIEF published on 03/27/2025 at 07:50, 1 year 4 months ago Eckert & Ziegler Reports Record Year in 2024 Eckert & Ziegler 2024 Financial Results Medical Segment Isotope Products 2025 Forecast
PRESS RELEASE published on 03/27/2025 at 07:45, 1 year 4 months ago Eckert & Ziegler: Record year 2024 with new all-time highs Eckert & Ziegler SE achieved record sales of €295.8 million in 2024, with significant growth in Medical and Isotope Products segments. Forecasting sales of €320 million and EBIT of €78 million for 2025 Record Sales Eckert & Ziegler SE 2024 Financial Year Medical Segment Isotope Products Segment
BRIEF published on 03/25/2025 at 09:35, 1 year 4 months ago Eckert & Ziegler to Provide Actinium Pharmaceuticals with Actinium-225 Clinical Trials Acute Myeloid Leukemia Actinium-225 Supply Targeted Radiotherapy Global Shortage
Published on 08/01/2026 at 01:20, 20 hours 30 minutes ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 20 hours 35 minutes ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 21 hours 20 minutes ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 07/31/2026 at 23:20, 22 hours 30 minutes ago Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.
Published on 08/01/2026 at 16:35, 5 hours 14 minutes ago HIZENERGY Enters Global Top Tier with BloombergNEF Tier 1 Listing
Published on 07/31/2026 at 19:55, 1 day 1 hour ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA Reaches Agreement with Financing Partners on Extension of Standstill Agreement and Continuation of Restructuring Process
Published on 07/31/2026 at 19:05, 1 day 2 hours ago Eurobattery Minerals presents the Q2 report for 2026 as the Company accelerates the development of the San Juan tungsten project
Published on 07/31/2026 at 18:53, 1 day 2 hours ago Deutsche EuroShop SE: Conversion into a European Company Successfully Completed
Published on 07/31/2026 at 21:00, 1 day ago Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:13, 1 day 2 hours ago Covivio - Information on Treasury shares transactions between July 29th, 2026 and July 31st, 2026
